One in 12 persons worldwide are living with either chronic hepatitis B or hepatitis C. It has higher prevalence rate than HIV or any cancer in the world - WHO
image by: American Liver Foundation
I so vividly remember one of my earliest encounters with viral hepatitis. I was working in Hacettepe University Hospital in Turkey when a seriously ill old woman was admitted. Her belly was swollen -- the size of a full-term pregnancy -- but there was no baby. Her abdomen was full of fluids because her liver had stopped functioning properly. She was dying from chronic liver disease due to viral hepatitis.
Viral hepatitis -- a group of infectious diseases caused by hepatitis A, B, C, D and E viruses -- can lead to liver cirrhosis and cancer, both horrible diseases to have -- and to die from.
It was years before I learned quite how many people there are in the world living…
I was stunned when I learned that hepatitis kills 1.4 million people every year, making it one of the world's top-10 killers along with ischemic heart disease, HIV/AIDS and lung cancer.
Hep is an award-winning print and online brand for people living with and affected by viral hepatitis. Offering unparalleled editorial excellence since 2010, Hep and HepMag.com are the go-to source for educational and social support for people living with hepatitis.
Viral hepatitis -- a group of infectious diseases known as hepatitis A, B, C, D, and E -- affects millions of people worldwide, causing both acute (short-term) and chronic (long-term) liver disease. Viral hepatitis causes more than one million deaths each year. While deaths from tuberculosis and HIV have been declining, deaths from hepatitis are increasing. In order to raise awareness of this hidden epidemic, the World Health Assembly designated July 28th as World Hepatitis Day.
Whether you are a patient, a family member, a friend, a health care/service provider, or just someone who wants to know more about hepatitis or our organization, this site will provide you with information about the work we do and the issues facing hepatitis patients.
The Hepatitis Foundation International is dedicated to liver health and the prevention of liver related diseases. We inform and educate by making available reliable and up-to-date facts. We want you to make well-informed decisions for yourself and your loved ones' health and well-being. We are proud to present this website as your personal Internet gateway to hepatitis information and liver care.
Through better awareness, prevention, care, support and access to treatment, our ultimate goal is to work with our members, governments and other key partners to eradicate these diseases from the planet. We provide global leadership and support action that will halt the viral hepatitis death toll and improve lives.
Hepatitis A is the only common vaccine-preventable foodborne disease in the United States (Fiore, 2004). It is one of five human hepatitis viruses that primarily infect the human liver and cause human illness.
We want you to have accurate, timely information, and that is why we've created The Support Partnership - a network of four nationally recognized nonprofits that have nearly 90 years of combined experience with peer helplines, hepatitis C support, education, testing, treatment, and advocacy.
Viruses that primarily attack the liver are called hepatitis viruses. There are several types of hepatitis viruses including types A, B, C, D, E, and possibly G. Types A, B, and C are the most common.
Hepatitis Australia, incorporated in 1997, is the peak community organisation to progress national action on issues of importance to people affected by hepatitis B and hepatitis C.
The focus of the Hepatitis C Association is to educate the public, both patients and medical providers, about hepatitis C virus. We offer factual information through educational programs and support materials.
All the information you need about living with Hepatitis C, including the latest news about infection, transmission, symptoms, treatment breakthroughs and medical progress.
In 1977, Dr. Mario Rizzetto and associates discovered in Italy, in patients affected by Hepatitis B a new antigen different than surface, core and e systems that they called "delta antigen". (Gut 18:997-1003,1977).
We are a not-for-profit charity started by the hepatitis community. Together we inform, support and educate.
Hepatitis Queensland is committed to improving liver health for ALL Queenslanders. We are a community-based, non-government organisation that represents the interests of people affected by, or at risk of viral hepatitis and liver disease. Our mission is to address stigma, improve the lives of those affected by viral hepatitis and meet emerging liver health challenges.
Latest news about HIV, hepatitis B, and hepatitis C, including medical journal summaries and conference coverage.
The aim of infohep.org is to develop a high-quality online resource to increase awareness of viral hepatitis, its treatment, and the needs of people living with viral hepatitis in Europe.
The Journal of Viral Hepatitis publishes reviews, original work (full papers) and short, rapid communications in the area of viral hepatitis. It solicits these articles from epidemiologists, clinicians, pathologists, virologists and specialists in transfusion medicine working in the field, thereby bringing together in a single journal the important issues in this expanding speciality.
The National Viral Hepatitis Roundtable (NVHR) is a coalition of public, private and voluntary organizations dedicated to reducing the incidence of infection, morbidity and mortality from viral hepatitis in the United States. We accomplish this by advocating for at-risk populations, convening visionary leaders and coordinating a unified national response to viral hepatitis based on current research.
The Viral Hepatitis Action Coalition is a public-private partnership developed by the CDC Foundation to help the Centers for Disease Control and Prevention (CDC) make meaningful advances in the prevention, screening and treatment of viral hepatitis.
Hepatitis is a general term that refers to inflammation of the liver. This condition may result from various infectious (viral, bacterial, fungal, and parasitic organisms) and noninfectious (medications, toxins, and autoimmune disorders) causes; however, this article considers hepatitis caused by viral infection.
The objective of VHPB is to contribute to the control and prevention of viral hepatitides: 1. by drawing the attention to this important public health problem 2. by issuing prevention guidance and catalyse the development of recommendations, and 3. by encouraging actions to improve control and prevention.
The ABCs of Hepatitis.
CCO believes the way to optimize clinicians’ competence in providing the highest standards of evidence-based medicine is through effective education and the availability of the latest clinical information, whenever and wherever it is needed. CCO is dedicated to improving patient care by providing superior-quality, relevant educational content and clinical knowledge as delivered through its innovative and integrated online and mobile platforms, which provide comprehensive and personalized information solutions.
The latest Liver Disease News & Hepatitis News articles published daily. Includes news on Inflammation of the liver, cirrhosis, cysts, hepatitis A, B and C and much more.
What do drugs, alcohol, unprotected sex, tattoos, and body piercings have in common? They're all things your parents might lecture you about avoiding, but there's another connection: They can all lead to a liver condition called hepatitis.
Recognizing the tremendous burden caused by viral hepatitis, the World Health Assembly adopted resolution WHA63.18 in 2010, calling for a comprehensive approach to the prevention and control of viral hepatitis.
Your Path to Meaningful Connections in the World of Health and Medicine
Connect, Collaborate, and Engage!
Coming Soon - Stitches, the innovative chat app from the creators of HWN. Join meaningful conversations on health and medical topics. Share text, images, and videos seamlessly. Connect directly within HWN's topic pages and articles.